The International journal on drug policyOhioHumansFentanylXylazineDrug Overdose
Early evidence of the effects of xylazine-adulterated fentanyl in Ohio.
Daniel Rosenblum, George Karandinos, Jay Unick, Dennis Cauchon, Daniel Ciccarone
Published: 202510.1016/j.drugpo.2025.105066
Abstract
BACKGROUND: Xylazine is becoming a prevalent fentanyl adulterant in the US. It has been associated with severe wounds and withdrawal symptoms. However, its impact on fatal overdose rates is poorly understood. METHODS: Poisson and ordinary least squar…
Preview only. Read the full abstract at the source